Sildenafil is highly effective for treating erectile dysfunction (ED). Howe
ver, its use has been associated with serious adverse events including myoc
ardial infarctions and strokes, and 130 verifiable plus 112 unverified deat
hs reported to the US Food and Drug Administration during the 8 months afte
r sildenafil was introduced in the US, and 522 reported deaths during the 1
3.5 months after its introduction. Moreover, some events have occurred in m
en taking their first dose of the agent, suggesting that sildenafil, like s
ome drugs that affect blood pressure, may provoke a first-dose reaction. Th
is possibility warrants extra caution to be used when initiating treatment
with sildenafil. Such caution is not currently provided by the current dosa
ge guidelines that, for example, recommend the use of sildenafil 50mg initi
ally for most men between the ages of 18 and 65 years, despite wide differe
nces in bodyweight, age, drug metabolism, health status and usage of other
medications.
It can be difficult to identify the patient who may be unusually sensitive
to the effects of sildenafil. Exercise stress tests have been recommended,
but serious adverse events have occurred in men with normal stress tests fo
llowing the ingestion of sildenafil. Blood pressure monitoring following si
ldenafil administration will not prevent a serious adverse drug event alrea
dy in progress. This article discusses the advantages and disadvantages of
initiating treatment with a low test dose of sildenafil, performed at home
or in the doctor's office. The advantages of this approach include: (i) ide
ntifying patients who are highly sensitive to the effects of sildenafil and
who may need no higher dose; (ii) minimising adverse effects such as flush
ing and dizziness that often frighten patients and may affect adherence; (i
ii) avoidance of major adverse events; and (iv) reassuring patients with ED
who remain wary about trying sildenafil therapy.